Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Taiho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Taiho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Taiho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Taiho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Taiho Pharmaceutical Co Ltd, Medical Devices Deals, 2012 to YTD 2018 10
Taiho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Taiho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deal Details 13
Asset Purchase 13
Taiho Pharma Acquires Fermentation Research-Related Assets from Astellas Pharma 13
Venture Financing 14
ORIC Pharma Raises USD50 Million in Series C Financing 14
Storm Therapeutics Raises Additional USD5.4 Million in Series A Financing 16
Arcus Biosciences Raises USD107 Million in Series C Financing 17
Harpoon Therapeutics Raises USD45 Million in series B Financing 19
Arcus Biosciences Raises USD70 Million in Series B Financing 21
Partnerships 22
Taiho Pharma Enters into Co-Marketing Agreement with Janssen Pharma 22
X-Chem Enters into Agreement with Taiho Pharma 23
Merck Enters into Co-Promotion Agreement with Taiho Pharma for Pembrolizumab 24
Taiho Pharma Enters into Co-Marketing Agreement with Meiji Seika Pharma 25
Response Genetics Extends Agreement With Taiho Pharma For Molecular Markers 26
Licensing Agreements 27
Taiho Pharma Enters into Licensing Agreement with Arcus Biosciences 27
TTY Biopharm Enters into Licensing Agreement with Taiho Pharma 28
Taiho Pharma Enters into Licensing Agreement with Servier 29
Taiho Pharma Enters Into Licensing Agreement With Faes Farma For Bilastine 30
Taiho Pharmaceutical Co Ltd – Key Competitors 31
Taiho Pharmaceutical Co Ltd – Key Employees 32
Taiho Pharmaceutical Co Ltd – Locations And Subsidiaries 33
Head Office 33
Other Locations & Subsidiaries 33
Recent Developments 34
Strategy And Business Planning 34
Jun 02, 2017: Taiho Pharmaceutical to Construct Facility for Production of Highly Potent Pharmaceutical Ingredients 34
Mar 07, 2017: Taiho Pharmaceutical Announces Expansion into Canada 35
Product News 36
Oct 05, 2017: Taiho Pharmaceutical Releases Pitas Sore Throat Troche in Japan on October 5A Sticker-type Troche to be Placed on the Roof of the Mouth That is Helpful in Business Meetings 36
May 28, 2018: Taiho Pharmaceutical to Launch Tiovita Drink Aibitasu Zero Nationwide on May 28, 2018 “No fatigue the next day!” 37
Feb 07, 2017: Taiho Pharmaceutical Releases Pure Quick S Ointment, a New Mini Size Steroid Product 38
Clinical Trials 39
Apr 16, 2018: Taiho Pharmaceutical and Helsinn Group present preclinical data at AACR Annual Meeting for a RET inhibitor under co-development as an attractive compound for anticancer therapy 39
Other Significant Developments 40
Jul 03, 2018: Taiho Pharmaceutical Completes New Production Facility for Highly Potent Pharmaceutical Ingredients at Saitama Site 40
Appendix 41
Methodology 41
About GlobalData 41
Contact Us 41
Disclaimer 41
Taiho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Taiho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Taiho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Taiho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Taiho Pharmaceutical Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 9
Taiho Pharmaceutical Co Ltd, Medical Devices Deals, 2012 to YTD 2018 10
Taiho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Taiho Pharma Acquires Fermentation Research-Related Assets from Astellas Pharma 13
ORIC Pharma Raises USD50 Million in Series C Financing 14
Storm Therapeutics Raises Additional USD5.4 Million in Series A Financing 16
Arcus Biosciences Raises USD107 Million in Series C Financing 17
Harpoon Therapeutics Raises USD45 Million in series B Financing 19
Arcus Biosciences Raises USD70 Million in Series B Financing 21
Taiho Pharma Enters into Co-Marketing Agreement with Janssen Pharma 22
X-Chem Enters into Agreement with Taiho Pharma 23
Merck Enters into Co-Promotion Agreement with Taiho Pharma for Pembrolizumab 24
Taiho Pharma Enters into Co-Marketing Agreement with Meiji Seika Pharma 25
Response Genetics Extends Agreement With Taiho Pharma For Molecular Markers 26
Taiho Pharma Enters into Licensing Agreement with Arcus Biosciences 27
TTY Biopharm Enters into Licensing Agreement with Taiho Pharma 28
Taiho Pharma Enters into Licensing Agreement with Servier 29
Taiho Pharma Enters Into Licensing Agreement With Faes Farma For Bilastine 30
Taiho Pharmaceutical Co Ltd, Key Competitors 31
Taiho Pharmaceutical Co Ltd, Key Employees 32
Taiho Pharmaceutical Co Ltd, Subsidiaries 33
List of Figures
Taiho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Taiho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Taiho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Taiho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Taiho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Taiho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Taiho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Taiho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Taiho Pharmaceutical Co Ltd, Medical Devices Deals, 2012 to YTD 2018 10